KRYS vs. NVO
Compare and contrast key facts about Krystal Biotech, Inc. (KRYS) and Novo Nordisk A/S (NVO).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: KRYS or NVO.
Correlation
The correlation between KRYS and NVO is 0.20, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
KRYS vs. NVO - Performance Comparison
Key characteristics
KRYS:
-0.02
NVO:
-1.25
KRYS:
0.27
NVO:
-1.92
KRYS:
1.03
NVO:
0.75
KRYS:
-0.03
NVO:
-0.87
KRYS:
-0.06
NVO:
-1.81
KRYS:
15.85%
NVO:
28.67%
KRYS:
41.36%
NVO:
41.46%
KRYS:
-53.42%
NVO:
-70.96%
KRYS:
-21.10%
NVO:
-59.68%
Fundamentals
KRYS:
$4.87B
NVO:
$285.37B
KRYS:
$3.00
NVO:
$3.42
KRYS:
56.19
NVO:
16.98
KRYS:
16.77
NVO:
0.98
KRYS:
5.15
NVO:
11.88
KRYS:
$245.26M
NVO:
$225.05B
KRYS:
$225.64M
NVO:
$190.45B
KRYS:
$92.22M
NVO:
$113.24B
Returns By Period
In the year-to-date period, KRYS achieves a 7.60% return, which is significantly higher than NVO's -31.39% return.
KRYS
7.60%
-10.63%
-5.93%
6.33%
30.18%
N/A
NVO
-31.39%
-25.10%
-50.02%
-51.72%
14.53%
9.70%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
KRYS vs. NVO — Risk-Adjusted Performance Rank
KRYS
NVO
KRYS vs. NVO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Krystal Biotech, Inc. (KRYS) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
KRYS vs. NVO - Dividend Comparison
KRYS has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 2.78%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
KRYS Krystal Biotech, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVO Novo Nordisk A/S | 2.78% | 1.68% | 0.99% | 1.18% | 1.34% | 1.86% | 2.12% | 2.46% | 2.13% | 3.94% | 1.31% | 1.96% |
Drawdowns
KRYS vs. NVO - Drawdown Comparison
The maximum KRYS drawdown since its inception was -53.42%, smaller than the maximum NVO drawdown of -70.96%. Use the drawdown chart below to compare losses from any high point for KRYS and NVO. For additional features, visit the drawdowns tool.
Volatility
KRYS vs. NVO - Volatility Comparison
The current volatility for Krystal Biotech, Inc. (KRYS) is 13.69%, while Novo Nordisk A/S (NVO) has a volatility of 15.88%. This indicates that KRYS experiences smaller price fluctuations and is considered to be less risky than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
KRYS vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between Krystal Biotech, Inc. and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities